Cite Filings / AVTX / 0001628280-17-009991

Feed Companies Filings Check

Sign in

424B3

Prospectus

Avalo Therapeutics, Inc. Filed 2017-10-20 Acc 0001628280-17-009991

Documents 1

424B3 Prospectus , cerc424b38kdirectorresigna.htm

Around this filing

2017-11-07 424B3 Prospectus
2017-10-20 424B3 Prospectus
2017-10-20 8-K Executive or director change
2017-10-18 424B3 Prospectus
2017-10-18 8-K/A Delisting notice
2017-10-18 4 Changes in Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading cerc424b38kdirectorresigna.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…